Form 4: Bluebird Bio Executive Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Joseph Vittiglio, Chief Business & Legal Officer of bluebird bio, sold 238 shares of common stock on February 3, 2025, to cover tax withholding obligations.
Summary
- Joseph Vittiglio, the Chief Business & Legal Officer of bluebird bio, Inc., sold 238 shares of common stock on February 3, 2025.
- The sale was executed to cover tax withholding obligations related to the vesting of Restricted Stock Units.
- The shares were sold at an average weighted price of $7.3925, with individual prices ranging from $7.27 to $7.55.
- Following the transaction, Vittiglio directly owns 4,501 shares of bluebird bio, Inc.
- The number of securities reported have been adjusted to reflect a 1-for-20 reverse stock split effected by the Issuer on December 12, 2024.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing related to an insider stock sale for tax purposes. It doesn't inherently convey positive or negative sentiment.
Industry Context
This is a routine Form 4 filing, indicating an insider transaction. Such filings are common and provide transparency into the trading activities of company executives. The sale is related to tax obligations, which is a typical reason for such transactions.
Key Dates
| Date | Description |
|---|---|
| 2024-09-23 | Date of Power of Attorney execution. |
| 2024-12-12 | bluebird bio effected a 1-for-20 reverse stock split. |
| 2025-02-03 | Date of stock sale transaction. |
| 2025-02-05 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.